Clinical and Brain Activity Assessment Before and After Physiotherapy in People With Chronic Non-specific Neck Pain
Predictors of Response After Physiotherapy Treatment in People With Chronic Non-specific Neck Pain
The goal of this clinical trial is to investigate whether electroencephalographic features are associated with the multidimensional clinical characteristics of adults with chronic non-specific neck pain and whether clinical and brain function measures change following physiotherapy. Participants with chronic non-specific neck pain will receive six weekly treatment sessions consisting of a manual physiotherapy and neck-specific exercise programme, including a home exercise programme. Clinical, psychophysical, and 64-channel electroencephalographic assessments will be performed at baseline and approximately one week after completion of the intervention. Clinical outcomes will also be reassessed 12 weeks after the last treatment session. Electroencephalographic recordings will be obtained while participants are seated comfortably and instructed to remain relaxed. EEG-derived measures will be examined in relation to pain intensity, neck-related disability, psychological and cognitive-affective factors, sleep quality, and psychophysical pain responses. Healthy participants without chronic neck pain will undergo a comparable baseline assessment to provide reference data for the interpretation of brain function in the clinical group.
調査の概要
詳細な説明
This non-randomized interventional study aims to investigate clinical and electroencephalographic characteristics in individuals with chronic non-specific neck pain and to examine changes following a physiotherapy intervention. A healthy control group will also be assessed to provide reference data for comparison with participants with chronic non-specific neck pain.
Participants with chronic non-specific neck pain will undergo a baseline assessment including clinical questionnaires, pain mapping, quantitative sensory testing, and 64-channel electroencephalographic recordings.
Following the baseline assessment, participants with chronic non-specific neck pain will receive six weekly physiotherapy sessions. The intervention will include passive mobilizations of the cervical and thoracic spine, soft tissue mobilizations, and a neck-specific home exercise programme involving neck flexor and extensor training.
The clinical, psychophysical, and electroencephalographic assessments will be repeated approximately one week after completion of the intervention. Perceived recovery, pain intensity, and neck-related disability will also be evaluated approximately 12 weeks after the final treatment session.
The study will examine baseline differences between participants with chronic non-specific neck pain and healthy controls and changes in clinical and electroencephalographic outcomes following physiotherapy.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Guipuzcoa
-
San Sebastián、Guipuzcoa、スペイン、20012
- 募集
- Ander Cervantes Benítez
-
コンタクト:
- Ander Cervantes Benítez
- 電話番号:5247 34 943 32 66 00
- メール:ander.cervantes@deusto.es
-
副調査官:
- Ander Cervantes Benítez
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Chronic non-specific neck pain (>3 months duration)
- Willing and able to sign informed consent for study participation
Exclusion Criteria:
- Concomitant neurological or psychiatric disease apart from depression (especially severe mental disorder or psychopathology)
- Regular (daily) intake of benzodiazepines
- Signs of severe disease, cervical myelopathy, tumour, rheumatic diseases or a neurological pathology of central origin
- Neck pain of traumatic origin or as a result of whiplash
- Previous surgical intervention of the cervical spine
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Physiotherapy group
Participants with chronic non-specific neck pain will receive a 6-week physiotherapy intervention consisting of six individual treatment sessions, including manual therapy directed at the cervical and thoracic regions, together with a home exercise program. Clinical and brain activity assessments will be performed before the intervention and approximately one week after completion of the intervention. |
The physiotherapy intervention will consist of six weekly sessions combining manual physiotherapy and a neck-specific exercise programme. Manual physiotherapy will include passive mobilisations of the cervical and thoracic spine and soft tissue techniques. The exercise programme will include daily home exercises targeting cervical mobility and neuromuscular control, including neck flexor and neck extensor training. The intervention is based on the protocol described by Villanueva-Ruiz et al. (2025).
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Global Rating of Change (GROC) scale
時間枠:Post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)
|
It is a single-item patient-reported outcome that aims to quantify a patient's perceived improvement or deterioration over time. The questionnaire is scored with 7 positive items to assess the patient's subjective improvement progressively. It also presents 7 negative items to assess whether the patient has worsened. The 0 is defined as no improvement or worsening. |
Post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Numeric Pain Rating Scale (NPRS)
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)
|
11-point tool used to measure pain intensity from 0 (no pain) to 10 (worst pain imaginable) |
Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)
|
|
Neck Disability Index (NDI)
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)
|
The Neck Disability Index consists of 10 items assessing disability related to neck pain. Each item is scored from 0 to 5, giving a total score from 0 to 50. Higher scores indicate greater neck-related disability. The score may also be expressed as a percentage from 0% to 100%. |
Baseline and post-intervention (approximately 1 week after treatment completion and 12 weeks after the last treatment session)
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Electroencephalographic spectral characteristics
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Spectral characteristics will be derived from 64-channel electroencephalography recorded while participants are seated comfortably with their eyes closed in a quiet environment and instructed to remain relaxed and minimize movement. Mean peak alpha frequency will be reported in hertz (Hz) at baseline and post-intervention. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Pain Catastrophizing Scale (PCS)
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
The Pain Catastrophizing Scale consists of 13 items scored from 0 to 4. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Hospital Anxiety and Depression Scale (HADS)
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Anxiety and depressive symptoms will be assessed using the 14-item Hospital Anxiety and Depression Scale. The anxiety and depression subscale scores will be summed to obtain a total score ranging from 0 to 42, with higher scores indicating greater psychological distress. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Central Sensitization Inventory (CSI)
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Symptoms associated with central sensitization will be assessed using Part A of the 25-item Central Sensitization Inventory. The total score ranges from 0 to 100, with higher scores indicating greater symptom severity. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Tampa Scale for Kinesiophobia-11
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Fear of movement will be assessed using the 11-item Tampa Scale for Kinesiophobia. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Sleep quality
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Sleep quality will be assessed using a single 0-to-10 numerical rating scale, where 0 indicates the worst possible sleep quality and 10 indicates the best possible sleep quality. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Pain mapping
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Participants will indicate the location and extent of their pain using a digital body chart. Total pain extent will be calculated as the percentage of the body chart area marked as painful. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Pressure pain threshold
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Pressure pain threshold will be assessed using a pressure algometer with a 1-cm² contact surface. Participants will be instructed to press a button when the sensation first changes from pressure to pain. Measurements will be performed at the most painful cervical location and at the contralateral hand. Three measurements will be obtained at each anatomical location, and the mean of the three measurements will be used for analysis. Values from the cervical location and the hand will be reported separately. Results will be reported in kilopascals. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Cold pain threshold
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Cold pain threshold will be assessed as part of a quantitative sensory testing protocol using the MSA Thermotest (Somedic) with a 9-cm² contact thermode. The baseline temperature will be set at 32°C, and the minimum safety limit will be 5°C. Temperature will decrease at a rate of 1°C/s. Participants will press a button when the cold sensation first becomes painful, immediately stopping the stimulus. Three valid consecutive measurements will be obtained, and their mean temperature will be used for analysis. Results will be reported in degrees Celsius. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Heat pain threshold
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Heat pain threshold will be assessed as part of a quantitative sensory testing protocol using the MSA Thermotest (Somedic) with a 9-cm² contact thermode. The baseline temperature will be set at 32°C, and the maximum safety limit will be 50°C. Temperature will increase at a rate of 1°C/s. Participants will press a button when the heat sensation first becomes painful, immediately stopping the stimulus. Three valid consecutive measurements will be obtained, and their mean temperature will be used for analysis. Results will be reported in degrees Celsius. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Temporal summation of pain
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Mechanical temporal summation of pain will be assessed using calibrated pinprick stimulators (MRC Systems). Participants will rate the perceived pain intensity of a single 256-mN pinprick stimulus and the overall pain intensity elicited by a series of 10 pinprick stimuli of the same force applied at a rate of 1 stimulus per second. Pain intensity will be rated using a numerical rating scale ranging from 0, no pain, to 10, worst imaginable pain. The temporal summation ratio will be calculated by dividing the pain rating for the series of 10 stimuli by the pain rating for the single stimulus. When the pain rating for the single stimulus is 0, a value of 1 will be used as the denominator to avoid division by zero. Higher ratios indicate greater temporal summation of pain. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
|
Conditioned pain modulation
時間枠:Baseline and post-intervention (approximately 1 week after treatment completion)
|
Conditioned pain modulation will be assessed using the cold pressor test as the conditioning stimulus and pressure pain threshold as the test stimulus. Participants will immerse the foot contralateral to the most painful cervical location in an insulated container filled with cold water, initially set at 10°C, for up to 2 minutes. The water temperature may be adjusted to achieve a pain intensity of approximately 5 out of 10. Immediately after removal of the conditioning stimulus, pressure pain threshold will be measured three times at the cervical location, with 15 seconds between measurements, and the mean of the three measurements will be used for analysis. The conditioned pain modulation response will be calculated as the absolute change in pressure pain threshold between the pre-conditioning and post-conditioning measurements and reported in kilopascals (kPa). Higher positive values indicate greater endogenous pain inhibition. |
Baseline and post-intervention (approximately 1 week after treatment completion)
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Furman AJ, Meeker TJ, Rietschel JC, Yoo S, Muthulingam J, Prokhorenko M, Keaser ML, Goodman RN, Mazaheri A, Seminowicz DA. Cerebral peak alpha frequency predicts individual differences in pain sensitivity. Neuroimage. 2018 Feb 15;167:203-210. doi: 10.1016/j.neuroimage.2017.11.042. Epub 2017 Nov 21.
- Chowdhury NS, Bi C, Furman AJ, Chiang AK, Skippen P, Si E, Millard SK, Margerison SM, Spies D, Keaser ML, Da Silva JT, Chen S, Schabrun SM, Seminowicz DA. A novel cortical biomarker signature predicts individual pain sensitivity. medRxiv [Preprint]. 2024 Nov 5:2024.06.16.24309005. doi: 10.1101/2024.06.16.24309005.
- Bott FS, Zebhauser PT, Hohn VD, Turgut O, May ES, Tiemann L, Gil Avila C, Heitmann H, Nickel MM, Day MA, Adhia DB, Ashar YK, Wager TD, Granovsky Y, Yarnitsky D, Jensen MP, Gross J, Ploner M. Exploring electroencephalographic chronic pain biomarkers: a mega-analysis. EBioMedicine. 2025 Oct;120:105955. doi: 10.1016/j.ebiom.2025.105955. Epub 2025 Sep 30.
- Heitmann H, Gil Avila C, Nickel MM, Ta Dinh S, May ES, Tiemann L, Hohn VD, Tolle TR, Ploner M. Longitudinal resting-state electroencephalography in patients with chronic pain undergoing interdisciplinary multimodal pain therapy. Pain. 2022 Sep 1;163(9):e997-e1005. doi: 10.1097/j.pain.0000000000002565. Epub 2021 Dec 15.
- Zabala Mata J, Lascurain-Aguirrebena I, Dominguez Lopez E, Azkue JJ. Enhanced Pronociceptive and Disrupted Antinociceptive Mechanisms in Nonspecific Chronic Neck Pain. Phys Ther. 2021 Mar 3;101(3):pzaa223. doi: 10.1093/ptj/pzaa223.
- Villanueva-Ruiz I, Falla D, Saez M, Araolaza-Arrieta M, Azkue JJ, Arbillaga-Etxarri A, Lersundi A, Lascurain-Aguirrebena I. Manual therapy and neck-specific exercise are equally effective for treating non-specific neck pain but only when exercise adherence is maximised: A randomised controlled trial. Musculoskelet Sci Pract. 2025 Jun;77:103319. doi: 10.1016/j.msksp.2025.103319. Epub 2025 Mar 21.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- FST_CCNE
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
A final decision regarding individual participant data sharing has not yet been made. Pseudonymized individual participant data underlying the results reported in the main publications may be made available through an Open Science Framework repository upon publication. Data sharing will depend on participant consent, approval by the study investigators and relevant ethics bodies, and compliance with applicable data protection and institutional requirements.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。